These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3517076)

  • 1. The influence of pindolol and hydrochlorothiazide on blood pressure, and plasma renin and plasma lipid levels.
    Johnson BF; Weiner B; Marwaha R; Johnson J
    J Clin Pharmacol; 1986 Apr; 26(4):258-63. PubMed ID: 3517076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients.
    Lancaster R; Goodwin TJ; Peart WS
    Br J Clin Pharmacol; 1976 Jun; 3(3):453-60. PubMed ID: 973972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparison of indoramin and pindolol added to hydrochlorothiazide for the treatment of mild to moderate hypertension.
    Luomanmäki K; Hartikainen M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S63-7. PubMed ID: 2423800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pindolol on potassium homeostasis in patients with essential hypertension.
    Garrett BN; Ram CV; Kaplan NM
    Clin Ther; 1984; 6(4):524-35. PubMed ID: 6547878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of pindolol and a thiazide diuretic on plasma lipids and blood pressure in patients with essential hypertension.
    Neusy AJ; Valeri A
    J Hum Hypertens; 1990 Aug; 4(4):453-7. PubMed ID: 2258893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pindolol on changes in serum lipids induced by hydrochlorthiazide.
    Frithz G
    Eur J Clin Pharmacol; 1989; 37(3):221-3. PubMed ID: 2612534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y; Gagné C
    J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind factorial trial of prindolol and hydrochlorothiazide in hypertension.
    Chalmers JP; Korner PI; Tiller DJ; Bune AJ; Steiner JD; West MJ; Wing LM; Uther JF
    Med J Aust; 1976 May; 1(18):650-3. PubMed ID: 781495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertension with hydrochlorothiazide and pindolol--good for the lipid pattern].
    Frithz G
    Lakartidningen; 1989 Jul; 86(28-29):2531-3. PubMed ID: 2674568
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
    Med J Aust; 1989 Jun; 150(11):646, 648, 651-2. PubMed ID: 2657348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of once daily indapamide and pindolol on blood pressure, plasma aldosterone concentration and plasma renin activity in a general practice setting.
    Chalmers JP; Wing LM; Grygiel JJ; West MJ; Graham JR; Bune AJ
    Eur J Clin Pharmacol; 1982; 22(3):191-6. PubMed ID: 7049706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pindolol: effects on blood pressure and plasma renin activity.
    Glassock RJ; Weitzman RE; Bennett CM; Maxwell M; Hamilton B; Winer N; Kirkendall W; Gonasun L
    Am Heart J; 1982 Aug; 104(2 Pt 2):421-5. PubMed ID: 7048878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of timolol and hydrochlorothiazide on blood-pressure and plasma renin activity. Double-blind factorial trial.
    Chalmers J; Tiller D; Horvath J; Bune A
    Lancet; 1976 Aug; 2(7981):328-31. PubMed ID: 60566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension.
    Masoni A; Galassi A; Ginevrino P; Libretti A; Morgagni W; Rappelli A; Tomasi AM
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):546-50. PubMed ID: 6757152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-adrenergic receptor blocking drugs, hypertension and plasma renin.
    Morgan TO; Roberts R; Carney SL; Louis WJ; Doyle AE
    Br J Clin Pharmacol; 1975 Apr; 2(2):159-64. PubMed ID: 791319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pindolol on serum lipids, apolipoproteins, and lipoproteins in patients with mild to moderate essential hypertension.
    Sasaki J; Saku K; Ideishi M; Arakawa K; Kato Y; Kuwano E; So T
    Clin Ther; 1989; 11(2):219-24. PubMed ID: 2736568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension.
    Samuel P; Chin B; Fenderson RW; Schoenfeld BH; Gonasun LM; Lieberman S
    Am J Cardiol; 1986 Feb; 57(5):24C-28C. PubMed ID: 3946247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antihypertensive efficacy of hydrochlorothiazide is not prostacyclin dependent.
    Gerber JG; LoVerde M; Byyny RL; Nies AS
    Clin Pharmacol Ther; 1990 Oct; 48(4):424-30. PubMed ID: 2225702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.